Sign In / Join

close

Conferences

Our Conferences articles contain the latest coverage of medical advancements from recent academic conferences.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

CAR T-Cell Therapy: Long-Term Side Effects and Patient Outcomes from ASH 2024

December 23, 2024

CAR T-cell therapy's long-term effects, patient-reported outcomes, and infection management strategies from ASH 2024. Expert insights from leading oncologists.

Breaking Potential New Standard of Care for Relapsed/Refractory Follicular Lymphoma Patients

December 17, 2024

Discover how adding tafasitamab to lenalidomide + rituximab improves outcomes for relapsed/refractory follicular lymphoma patients.

Bendamustine Before CAR T-cell Therapy Shows Lower Side Effects While Maintaining Efficacy

December 17, 2024

ASH 2024: bendamustine lymphodepletion before CAR T-cell therapy in aggressive lymphomas leads to fewer side effects while maintaining survival benefits.

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

December 10, 2024

Read research highlights from the ASH 2024 conference how certain lifestyle choices affect blood cancers.

The Best of ASH 2024

December 10, 2024

Discover the board's selection of best abstracts at the 66th annual ASH conference.

What Research is Being Discussed for DLBCL at ASH 2024?

December 08, 2024

Read about some of today’s DLBCL research topics presented at the ASH 2024 conference.

Follicular Lymphoma Specialists Share Insights on New Treatments

December 07, 2024

Learn about new treatments and recommendations to current therapies from follicular lymphoma specialists speaking at the 2024 ASH conference.

What is the ASH Conference?

December 02, 2024

The American Society of Hematology's annual conference is a significant event for the blood cancer community, including those involved in DLBCL research.

What is the ASH Conference?

December 02, 2024

The American Society of Hematology's annual conference is a significant event for the blood cancer community, including those involved in FL research.

Real-world Results for Preventing Infections in CLL and Non-Hodgkin Lymphoma Patients

November 15, 2024

New study shows IVIG replacement lowers infection risk in CLL and NHL patients, highlighting the need for better IgG testing and IgRT guidelines.

Conferences

Recent Articles

CAR T-Cell Therapy: Long-Term Side Effects and Patient Outcomes from ASH 2024

Breaking Potential New Standard of Care for Relapsed/Refractory Follicular Lymphoma Patients

Bendamustine Before CAR T-cell Therapy Shows Lower Side Effects While Maintaining Efficacy

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

The Best of ASH 2024

What Research is Being Discussed for DLBCL at ASH 2024?

Follicular Lymphoma Specialists Share Insights on New Treatments

What is the ASH Conference?

What is the ASH Conference?

Real-world Results for Preventing Infections in CLL and Non-Hodgkin Lymphoma Patients

Trending Articles

Trial Updates on Zynlonta Combinations for DLBCL

CAR T-Cell Therapy: Long-Term Side Effects and Patient Outcomes from ASH 2024

Education

Community

Cure Hub

Get Involved

About us

Need Help?

Legal Info

Conferences

Recent Articles

CAR T-Cell Therapy: Long-Term Side Effects and Patient Outcomes from ASH 2024

Breaking Potential New Standard of Care for Relapsed/Refractory Follicular Lymphoma Patients

Bendamustine Before CAR T-cell Therapy Shows Lower Side Effects While Maintaining Efficacy

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

The Best of ASH 2024

What Research is Being Discussed for DLBCL at ASH 2024?

Follicular Lymphoma Specialists Share Insights on New Treatments

What is the ASH Conference?

What is the ASH Conference?

Real-world Results for Preventing Infections in CLL and Non-Hodgkin Lymphoma Patients

Trending Articles

Trial Updates on Zynlonta Combinations for DLBCL

CAR T-Cell Therapy: Long-Term Side Effects and Patient Outcomes from ASH 2024

Get the latest thought leadership on your Non-Hodgkin Lymphoma delivered straight

Education

Community

Cure Hub

Get Involved

About us

Need Help?

Legal Info